New York Life Investment Management’s Aligos Therapeutics ALGS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,553	Closed	-$251K	–	1204
2022 Q4	$251K	Buy	10,553 +1,189	+13%	+$28.3K	﹤0.01%	1151
2022 Q3	$258K	Buy	9,364 +688	+8%	+$19K	﹤0.01%	1140
2022 Q2	$262K	Buy	+8,676	New	+$262K	﹤0.01%	1190